Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D W Bonhaus

Showing results (51-60 of 61) with videos related to

Pageof 7
Sort By:
Psychopharmacology|April 16, 1998
Enhanced delayed matching performance in younger and older macaques administered the 5-HT4 receptor agonist, RS 17017A V Terry, J J Buccafusco, W J Jackson, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 1, 1994
[3H]RS-23597-190, a potent 5-hydroxytryptamine4 antagonist labels sigma-1 but not sigma-2 binding sites in guinea pig brainD W Bonhaus, D N Loury, L B Jakeman, et al.
Biochemical Pharmacology|May 30, 1998
Ligand efficacy and potency at recombinant alpha2 adrenergic receptors: agonist-mediated [35S]GTPgammaS bindingJ R Jasper, J D Lesnick, L K Chang, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|July 1, 1996
Comparison of 5-HT4 receptors in guinea-pig colon and rat oesophagus: effects of novel agonists and antagonistsE Leung, M T Pulido-Rios, D W Bonhaus, et al.
Neuropharmacology|April 1, 1997
[3H]RS 57639, a high affinity, selective 5-HT4 receptor partial agonist, specifically labels guinea-pig striatal and rat cloned (5-HT4S and 5-HT4L) receptorsD W Bonhaus, J Berger, N Adham, et al.
British Journal of Pharmacology|May 1, 1995
Functional evidence equating the pharmacologically-defined alpha 1A- and cloned alpha 1C-adrenoceptor: studies in the isolated perfused kidney of ratD R Blue, D W Bonhaus, A P Ford, et al.
British Journal of Pharmacology|August 1, 1997
Catecholamine modulatory effects of nepicastat (RS-25560-197), a novel, potent and selective inhibitor of dopamine-beta-hydroxylaseW C Stanley, B Li, D W Bonhaus, et al.
Journal of Medicinal Chemistry|September 3, 1993
2-(Quinuclidin-3-yl)pyrido[4,3-b]indol-1-ones and isoquinolin-1-ones. Potent conformationally restricted 5-HT3 receptor antagonistsR D Clark, A B Miller, J Berger, et al.
Neuropharmacology|April 1, 1997
RS-102221: a novel high affinity and selective, 5-HT2C receptor antagonistD W Bonhaus, K K Weinhardt, M Taylor, et al.
British Journal of Pharmacology|August 24, 1999
RS-127445: a selective, high affinity, orally bioavailable 5-HT2B receptor antagonistD W Bonhaus, L A Flippin, R J Greenhouse, et al.
Pageof 7

Showing results (51-60 of 61) with videos related to

Sort By:
Pageof 7
Psychopharmacology|April 16, 1998
Enhanced delayed matching performance in younger and older macaques administered the 5-HT4 receptor agonist, RS 17017A V Terry, J J Buccafusco, W J Jackson, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 1, 1994
[3H]RS-23597-190, a potent 5-hydroxytryptamine4 antagonist labels sigma-1 but not sigma-2 binding sites in guinea pig brainD W Bonhaus, D N Loury, L B Jakeman, et al.
Biochemical Pharmacology|May 30, 1998
Ligand efficacy and potency at recombinant alpha2 adrenergic receptors: agonist-mediated [35S]GTPgammaS bindingJ R Jasper, J D Lesnick, L K Chang, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|July 1, 1996
Comparison of 5-HT4 receptors in guinea-pig colon and rat oesophagus: effects of novel agonists and antagonistsE Leung, M T Pulido-Rios, D W Bonhaus, et al.
Neuropharmacology|April 1, 1997
[3H]RS 57639, a high affinity, selective 5-HT4 receptor partial agonist, specifically labels guinea-pig striatal and rat cloned (5-HT4S and 5-HT4L) receptorsD W Bonhaus, J Berger, N Adham, et al.
British Journal of Pharmacology|May 1, 1995
Functional evidence equating the pharmacologically-defined alpha 1A- and cloned alpha 1C-adrenoceptor: studies in the isolated perfused kidney of ratD R Blue, D W Bonhaus, A P Ford, et al.
British Journal of Pharmacology|August 1, 1997
Catecholamine modulatory effects of nepicastat (RS-25560-197), a novel, potent and selective inhibitor of dopamine-beta-hydroxylaseW C Stanley, B Li, D W Bonhaus, et al.
Journal of Medicinal Chemistry|September 3, 1993
2-(Quinuclidin-3-yl)pyrido[4,3-b]indol-1-ones and isoquinolin-1-ones. Potent conformationally restricted 5-HT3 receptor antagonistsR D Clark, A B Miller, J Berger, et al.
Neuropharmacology|April 1, 1997
RS-102221: a novel high affinity and selective, 5-HT2C receptor antagonistD W Bonhaus, K K Weinhardt, M Taylor, et al.
British Journal of Pharmacology|August 24, 1999
RS-127445: a selective, high affinity, orally bioavailable 5-HT2B receptor antagonistD W Bonhaus, L A Flippin, R J Greenhouse, et al.
Pageof 7